arrow
T

Teresa Amaral

Eberhard Karls University of Tubingen
H指数:38
被引数:4,786

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study

基于皮肤镜的国际回顾性人工阅读研究的黑色素瘤转移预测模型

2025-12-080
OAAI
Messages for ultraviolet-radiation protection to fair-skinned populations

关于紫外线防护的信息,面向肤色较浅的人群

2025-11-060
OAAI
Genetic susceptibility in early-onset melanoma: An observational Greek cohort study

早期黑色素瘤的遗传易感性:一项希腊队列观察研究

2025-11-010
PRE
Outcome of systemic therapy in patients with advanced rare skin cancers: a retrospective multicenter DeCOG study of 209 patients

晚期罕见皮肤癌患者系统性治疗的结局:一项包含209名患者的回顾性多中心DeCOG研究

2025-08-300
PREAI
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation

辅助抗PD-1疗法可改善具有高肿瘤突变负荷和BRAF V600突变的IIIC-IV期黑色素瘤患者的黑色素瘤特异性生存率。

2025-08-130
OA
Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma.

新辅助病灶内靶向免疫细胞因子(Daromun)在III期黑色素瘤中的应用。

2025-07-070
PREAI
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

ESMO临床获益程度量表2.0版(ESMO-MCBS v2.0)

2025-05-220
PRE
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy

使用Merlin Assay (CP-GEP)对未进行前哨淋巴结活检的930例临床Ⅰ/Ⅱ期黑色素瘤患者独立队列进行风险分层

2025-05-010
OAAI
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

皮肤黑色素瘤:ESMO 临床实践指南(用于诊断、治疗和随访)

2025-01-0111
PRE
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma
2024-10-230
PRE
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade
2024-10-011
PRE
Exploiting gp100-specific antibodies isolated from immune checkpoint inhibitor-responsive melanoma patients to target tumor cells

利用从免疫检查点抑制剂应答的黑色素瘤患者中分离的gp100特异性抗体靶向肿瘤细胞

2024-09-010
PRE
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

皮肤癌是皮肤白皙人群中最常见的癌症,但我们可以预防它们。

2024-06-018
OA
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

免疫检查点抑制剂治疗患者类固醇难治性免疫相关不良事件的二线治疗

2024-05-013
OAAI